Form 4: Monte Rosa Therapeutics Executive Sells Shares
Statement of Changes in Beneficial Ownership
Philip Nickson, Chief Business & Legal Officer at Monte Rosa Therapeutics, Inc., reported a sale of 5,845 shares of common stock.
Summary
- Philip Nickson, Chief Business & Legal Officer of Monte Rosa Therapeutics, Inc., sold 5,845 shares of common stock on April 9, 2026.
- The sale was executed at a weighted average price of $17.6925 per share, with individual transactions ranging from $17.6901 to $17.71.
- Following this transaction, Nickson beneficially owns 55,000 shares of common stock directly.
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a neutral to slightly negative filing due to an executive selling shares, which can sometimes signal a lack of confidence, though the sale was executed under a pre-planned 10b5-1 trading plan.
Negatives
- An executive of the company sold a significant number of shares.
Future Outlook
No forward-looking statements or guidance were provided in this filing.
Industry Context
StockSavvy.ai notes that Form 4 filings are standard disclosures for executive stock transactions. While this filing indicates a sale by an executive, it does not provide insight into the company's overall financial health or future prospects.
Stakeholder Impact
- Shareholders may view the executive's stock sale with caution, although the transaction was made pursuant to a Rule 10b5-1 trading plan, which is designed to avoid insider trading concerns.
Key Dates
| Date | Description |
|---|---|
| 04/09/2026 | Date of transaction (sale of common stock). |
| 04/10/2026 | Date of signature on the filing. |
Keywords
Form 4, SEC Filing, Stock Sale, Insider Trading, Monte Rosa Therapeutics, Philip Nickson, Common Stock
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.